A |
2023-01-31 |
|
Rubius Therapeutics, Inc. |
4 |
M-Exempt |
--D |
8625.0000 |
20984.0000 |
2 |
0001709401 |
Common Stock |
D |
2023-01-31 |
|
Rubius Therapeutics, Inc. |
4 |
S-Sale |
--D |
2593.0000 |
18391.0000 |
3 |
0001709401 |
Common Stock |
D |
2023-01-31 |
|
Rubius Therapeutics, Inc. |
4 |
M-Exempt |
--D |
8625.0000 |
25875.0000 |
5 |
0001709401 |
Restricted Stock Units |
A |
2023-01-29 |
|
Rubius Therapeutics, Inc. |
4 |
M-Exempt |
--D |
7438.0000 |
12359.0000 |
1 |
0001709401 |
Common Stock |
D |
2023-01-29 |
|
Rubius Therapeutics, Inc. |
4 |
M-Exempt |
--D |
7438.0000 |
14874.0000 |
4 |
0001709401 |
Restricted Stock Units |
D |
2022-02-01 |
|
Rubius Therapeutics, Inc. |
4 |
S-Sale |
--D |
2517.0000 |
4921.0000 |
2 |
0001709401 |
Common Stock |
A |
2022-01-31 |
|
Rubius Therapeutics, Inc. |
4 |
A-Award |
--D |
143750.0000 |
143750.0000 |
4 |
0001709401 |
Stock Option (Right to Buy) |
A |
2022-01-31 |
|
Rubius Therapeutics, Inc. |
4 |
A-Award |
--D |
34500.0000 |
34500.0000 |
5 |
0001709401 |
Restricted Stock Units |
A |
2022-01-29 |
|
Rubius Therapeutics, Inc. |
4 |
M-Exempt |
--D |
7438.0000 |
7438.0000 |
1 |
0001709401 |
Common Stock |
D |
2022-01-29 |
|
Rubius Therapeutics, Inc. |
4 |
M-Exempt |
--D |
7438.0000 |
22312.0000 |
3 |
0001709401 |
Restricted Stock Units |
A |
2021-01-29 |
|
Rubius Therapeutics, Inc. |
4 |
A-Award |
--D |
131250.0000 |
131250.0000 |
1 |
0001709401 |
Stock Option (Right to Buy) |
A |
2021-01-29 |
|
Rubius Therapeutics, Inc. |
4 |
A-Award |
--D |
29750.0000 |
29750.0000 |
2 |
0001709401 |
Restricted Stock Units |
A |
2020-01-31 |
|
Rubius Therapeutics, Inc. |
4 |
A-Award |
--D |
350000.0000 |
350000.0000 |
1 |
0001709401 |
Stock Option (Right to Buy) |
- |
- |
|
Rubius Therapeutics, Inc. |
3 |
- |
--- |
|
|
1 |
- |
- |